HUMAN GENOME SCIENCES INC
10-Q, EX-27.1, 2000-11-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: HUMAN GENOME SCIENCES INC, 10-Q, 2000-11-14
Next: BACK YARD BURGERS INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                         134,036
<SECURITIES>                                   703,313
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               848,969
<PP&E>                                          64,082
<DEPRECIATION>                                  31,074
<TOTAL-ASSETS>                               1,057,623
<CURRENT-LIABILITIES>                           23,154
<BONDS>                                        533,676
                                0
                                          0
<COMMON>                                         1,121
<OTHER-SE>                                     483,156
<TOTAL-LIABILITY-AND-EQUITY>                 1,057,623
<SALES>                                              0
<TOTAL-REVENUES>                                21,426
<CGS>                                                0
<TOTAL-COSTS>                                   64,709
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              15,724
<INCOME-PRETAX>                              (224,700)
<INCOME-TAX>                                       225
<INCOME-CONTINUING>                          (224,925)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (224,925)
<EPS-BASIC>                                     (2.09)
<EPS-DILUTED>                                   (2.09)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission